Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Gyre Therapeutics, Inc.
Business Segments
Business Segments
Net Segment Loss Income
Net Segment Loss Income
Gyre Therapeutics, Inc.
·
Business Segments
·
2 segments
Breakdown
Segments
Gyre Pharmaceuticals
View metric
Gyre
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q2 '26
Gyre
-$8.62M
Gyre Pharmaceuticals
-$5.64M
Total
-$5.64M
